Skip to main content
Clinical Trials/NCT03385187
NCT03385187UnknownNot Applicable

Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test

Ectosense NV1 site in 1 country450 target enrollmentStarted: June 29, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
450
Locations
1
Primary Endpoint
Apnea-Hypopnea Index (AHI)

Study Overview

Brief Summary

Prospective validation study of the NightOwl, a Type IV home sleep apnea test (HSAT), compared to a traditional Type I and a Type IV sleep monitor.

Detailed Description

The purpose of this prospective validation study is the evaluation of the accuracy of the NightOwl HSAT to derive parameters relevant for the diagnosis of sleep apnea. The NightOwl HSAT comprises a finger or forehead mounted sensor and an automated analytics software. The sensor measures double-wavelength photo-plethysmography and accelerometry. The analytics software automatically interprets the sensor data and derives a measure of sympathetic activation of the autonomic nervous system, oxygen saturation, instantaneous pulse rate and activity. For each patient in the cohort, the AHI derived by the NightOwl will be compared to that of the Type I sleep monitor (in-lab PSG), which will acquire data simultaneously during the diagnostic night of the patient referred to the sleep lab for a polysomnography. On a randomly selected subset of patients, a Type IV sleep monitor will additionally be applied for comparison of its automated AHI derivation to that of the NightOwl.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Indication for a sleep study

Exclusion Criteria

  • •Mentally disabled people
  • •Known allergy to Plexiglas (PMMA) or other acrylates

Arms & Interventions

NightOwl HSAT

Other

Patient undergoes a NightOwl sleep apnea test whilst simultaneously undergoing a sleep study with a Type I sleep monitor (Lab-PSG) and optionally a Type IV sleep monitor.

Intervention: NightOwl HSAT (Device)

Outcomes

Primary Outcomes

Apnea-Hypopnea Index (AHI)

Time Frame: At the time of the diagnostic night

Comparison of the AHI derived from the NightOwl HSAT to that of the Type I and Type IV sleep monitors

Secondary Outcomes

  • Sleep-wake discrimination(At time of the diagnostic night)

Investigators

Sponsor
Ectosense NV
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials